Evaluation of the efficicacy of myrcene in the treatment of Eimeria tenella and Toxoplasma gondii infection
Journal of Veterinary Medical Science · 2025
DOI: 10.1292/jvms.24-0397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Medical Science, 2025. Verfasst von Nianyuan Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Shandong Agricultural University, Tai'an, China. Hauptthemen laut MEDLINE: Eimeria tenella, Coccidiosis, Toxoplasma, Toxoplasmosis, Animal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Science and Technology Plan Projects of Tibet Autonomous Region, key R&D project of Shandong Province.
Abstract (Originalsprache)
Protozoan parasites such as Eimeria tenella and Toxoplasma gondii pose significant health challenges in livestock and humans. The limited treatment options and rising drug resistance underscore the urgent need for new therapies. This study investigates myrcene, a monoterpene hydrocarbon classified for its antiprotozoal potential against E. tenella and T. gondii infections. Initially, we examined its effect on the sporulation process of E. tenella oocysts in vitro and its anti-E. tenella activity in vivo. Myrcene significantly reduced the sporulation rate of E. tenella oocysts at 3 and 4 mg/kg. In vivo experiments demonstrated that treatment with 4 mg/kg myrcene significantly reduced E. tenella load and oocyst output, as well as cecal lesion and weight loss caused by E. tenella infection, showing moderate anti-E. tenella activity, with an Anticoccidial Index (ACI) of 161.4. Furthermore, we investigated the anti-T. gondii activity of myrcene both in vitro and in vivo. In vitro studies showed that treatment with myrcene effectively inhibited the invasion rate and intracellular proliferation ability of T. gondii tachyzoite in DF-1 cells in a dose-dependent manner. In vivo administration prolonged the survival time in T. gondii-infected mice, suggesting notable protective effects. Additionally, it mitigated T. gondii-induced hepatosplenic toxicity by reducing parasite load in the liver and spleen, and ameliorating liver function as evidenced by decreased serum transaminase levels. In conclusion, the findings demonstrate promising anti-E. tenella and anti-T. gondii activity exhibited by myrcene warranting further exploration into its mechanisms and potential therapeutic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Shandong Agricultural University, Tai'an, China.
- The National Animal Health Products for Engineering Technology Research Center, Qingdao, China.
- Shandong Provincial Key Laboratory of Zoonoses, Shandong Agricultural University, Tai'an, China.
Förderung
- Science and Technology Plan Projects of Tibet Autonomous Region
- key R&D project of Shandong Province
Zitieren
APA
Chen, N., Cai, Q., Wang, S., Song, Q., Xie, Y., Shi, H., Li, H., Zhao, X., Zhao, N., & Zhang, X. (2025). Evaluation of the efficicacy of myrcene in the treatment of Eimeria tenella and Toxoplasma gondii infection. Journal of Veterinary Medical Science. https://doi.org/10.1292/jvms.24-0397
Vancouver
Chen N, Cai Q, Wang S, Song Q, Xie Y, Shi H, et al. Evaluation of the efficicacy of myrcene in the treatment of Eimeria tenella and Toxoplasma gondii infection. Journal of Veterinary Medical Science. 2025. doi:10.1292/jvms.24-0397
BibTeX
@article{Chen2025,
author = {Chen, Nianyuan and Cai, Qingxiu and Wang, Shujing and Song, Qingyang and Xie, Ying and Shi, Huijuan and Li, Hongmei and Zhao, Xiaomin and Zhao, Ningning and Zhang, Xiao},
title = {Evaluation of the efficicacy of myrcene in the treatment of Eimeria tenella and Toxoplasma gondii infection},
journal = {Journal of Veterinary Medical Science},
year = {2025},
doi = {10.1292/jvms.24-0397}
}
EUVIMED